| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT00539188 Details | 2020-04-15 Interventional | 2 | 6 | Acetylcysteine N-monoacetylcys… Borderline Pers… Personality Dis… Self-Injurious … | Study terminated due to poor subject compliance. - | |||
| NCT03118713 Details | 2020-04-14 Interventional | 4 | 33 | Glimepiride Ipragliflozin Metformin Albuminuria Diabetes Mellit… Diabetes Mellit… Type 2 Diabetes… | Business decision due to enrollment challenges - | |||
| NCT01636609 Details | 2020-04-13 Interventional | 1 | 18 | Azacitidine Cytarabine Glycine Tosedostat Leukemia Leukemia, Myelo… Leukemia, Myelo… Myelodysplastic… Preleukemia Syndrome Acute Myeloid L… High Risk Myelo… | In 2013 the FDA put a temporary hold on the trial and the Phase II portion of this study was
cancelled. - | |||
| NCT03093272 Details | 2020-04-09 Interventional | 2 | 9 | Docetaxel Leuprolide Prednisone Prostatic Neopl… Prostate Cancer | Safety concerns - | |||
| NCT02503501 Details | 2020-04-09 Interventional | 2 | 49 | Insulin glulisi… Alzheimer Disea… Cognitive Dysfu… Alzheimer's Dis… Mild Cognitive … | Study will not have power to show a difference between groups. - | |||
| NCT02162433 Details | 2020-04-09 Interventional | 4 | 92 | Dexmedetomidine Hypertrophy Sleep Apnea, Ob… Tonsillitis Adenoiditis Adenotonsillar … Obstructive Sle… | Terminated due to a high number of protocol deviations secondary to non-study approved opioid
administration. - | |||
| NCT00353457 Details | 2020-04-09 Interventional | 2 | 6 | Capecitabine Cetuximab Oxaliplatin Adenocarcinoma Rectal Neoplasm… Rectal Cancer | new studies were finding that Erbitux was not beneficial - | |||
| NCT04069234 Details | 2020-04-08 Interventional | 3 | 0 | Clopidogrel Ticagrelor Coronary Artery… Diabetes Mellit… Myocardial Infa… Microvascular C… | Sponsor decided to stop the study due to commercial reasons. - | |||
| NCT03427021 Details | 2020-04-08 Interventional | 1 | 65 | Oxaliplatin Hypersensitivit… GI Patients on … | final study report has been completed and submitted - | |||
| NCT02263547 Details | 2020-04-03 Interventional | 1 | 14 | Colestipol Teriflunomide Healthy Volunte… Teriflunomide E… | PK time points were not being met as expected. Determination that risks outweighed benefit. small number of subjects analyzed with some lost to followup | |||
| NCT03002831 Details | 2020-04-02 Interventional | 2 | [2 Refs] | 13 | Tegafur Pancreatic Neop… Advanced Cancer | Study halted prematurely and will not resume - | ||
| NCT01847677 2012-003883-31 Details | 2020-04-01 Interventional | 2 | 71 | Bevacizumab Carboplatin Paclitaxel Carcinoma, Ovar… Ovarian Neoplas… Cancer, Ovarian | - - | |||
| NCT03680560 Details | 2020-03-31 Interventional | 1 | 6 | Trastuzumab HER-2 Protein O… Solid Tumor | Business Reasons - | |||
| NCT03232021 Details | 2020-03-31 Interventional | 2/3 | 0 | Pregabalin Pregabalin on C… | All patients during the study period were subjected to peripheral blocks or were excluded from
the study due to exclusion criteria - | |||
| NCT02855086 Details | 2020-03-31 Interventional | 1/2 | 3 | Antibodies Antibodies, Mon… Antineoplastic … Cetuximab Immunoglobulins Brain Neoplasms Glioma Neoplasms Brain Neoplasm Malignant Gliom… | logistics - | |||
| NCT02365870 Details | 2020-03-31 Interventional | 4 | 4 | Rotigotine Anxiety Disorde… Parkinson Disea… | Funding cycle completed - | |||
| NCT02622724 2014-005260-15 Details | 2020-03-30 Interventional | 3 | 301 | Interferon beta… Interferon-beta Interferons Acute Lung Inju… Respiratory Dis… Respiratory Dis… Syndrome Respiratory Dis… | Day 90 results indicate IMP did not reduce mortality or ventilator free days As the study was terminated early, only a limited amount of data was available at Day 180 and Day 360. | |||
| NCT00398008 Details | 2020-03-30 Interventional | 2 | 0 | Buprenorphine Naltrexone Opioid-Related … Substance-Relat… HIV Infections Opiate Dependen… | Study was never able to start in IRAN - | |||
| NCT04132011 Details | 2020-03-27 Interventional | 4 | 0 | Analgesics, Opi… Hydromorphone Morphine Oxycodone Chronic Pain | No recruitment (Feasibility study). - | |||
| NCT04024384 Details | 2020-03-27 Interventional | 2 | 0 | Daratumumab Multiple Myelom… Neoplasms, Plas… | Promotor decision - |